Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct;592(19):3229-3238.
doi: 10.1002/1873-3468.13238. Epub 2018 Sep 18.

NAD+ promotes assembly of the active tetramer of aldehyde dehydrogenase 7A1

Affiliations

NAD+ promotes assembly of the active tetramer of aldehyde dehydrogenase 7A1

David A Korasick et al. FEBS Lett. 2018 Oct.

Abstract

Nicotinamide adenine dinucleotide (NAD) is the redox cofactor of many enzymes, including the vast aldehyde dehydrogenase (ALDH) superfamily. Although the function of NAD(H) in hydride transfer is established, its influence on protein structure is less understood. Herein, we show that NAD+ -binding promotes assembly of the ALDH7A1 tetramer. Multiangle light scattering, small-angle X-ray scattering, and sedimentation velocity all show a pronounced shift of the dimer-tetramer equilibrium toward the tetramer when NAD+ is present. Furthermore, electron microscopy shows that cofactor binding enhances tetramer formation even at the low enzyme concentration used in activity assays, suggesting the tetramer is the active species. Altogether, our results suggest that the catalytically active oligomer of ALDH7A1 is assembled on demand in response to cofactor availability.

Keywords: aldehyde dehydrogenase; analytical ultracentrifugation; electron microscopy; enzyme oligomerization; nicotinamide adenine dinucleotide; small-angle X-ray scattering.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Reactions related to ALDH7A1 biology. ALDH7A1 catalyzes the oxidation of α-aminoadipate semialdehyde to α-aminoadipate, which is in non-enzymatic equilibrium with L-Δ1-piperideine-6-carboxylate.
Fig. 2.
Fig. 2.
SEC-SAXS analysis of ALDH7A1 in the presence and absence of NAD+. Each panel shows SEC-SAXS experimental data (open circles) and the corresponding FoXS single-body fit to the ALDH7A1 crystallographic tetramer (PDB ID: 4ZUK; cyan curve) or the MultiFoXS two-body ensemble fit to a theoretical mixture of ALDH7A1 crystallographic dimer and tetramer (PDB ID: 4ZUK; red curve). The top three panels display three increasing nominal concentrations (from left to right) of apo ALDH7A1. The bottom three panels display three increasing nominal concentrations (from left to right) of ALDH7A1 in the presence of 1 mM NAD+. The complete experimental SAXS data and Guinier plots are included in Fig. S2 for reference.
Fig. 3.
Fig. 3.
Sedimentation velocity analysis of ALDH7A1 in the absence (black) and presence (red) of NAD+. (A) The distribution of sedimentation coefficients, c(s). (B) The distribution of molecular masses, c(M). In both panels, the black curve depicts apo ALDH7A1 at 9 μM (dimer Mr), and the red curve depicts ALDH7A1 in the presence of 1 mM NAD+ at 9 μM (dimer Mr).
Fig. 4.
Fig. 4.
Negative-Stain EM of ALDH7A1 in the presence and absence of NAD+. (A) The crystal structure of ALDH7A1 (PDB ID: 4ZUK) shown as a ribbon in red with an overlaid envelope representing a 20 Å resolution view of both the dimer and tetramer. The 20 Å resolution envelope was generated using Chimera [49]. (B) Two-dimensional class averages for apo ALDH7A1 at 90 nM. (C) Two-dimensional class averages for 90 nM ALDH7A1 in the presence of 1 mM NAD+. For panels B and C, the letters ‘D’ or ‘T’ in the inset of each class average indicate classes that visually resemble the dimer or tetramer, respectively. Classes that lack a letter in the inset were not clearly dimeric or tetrameric.

References

    1. van Karnebeek CD et al. (2016). Pyridoxine-dependent epilepsy: An expanding clinical spectrum. Pediatr Neurol 59, 6–12. - PubMed
    1. Stockler S et al. (2011). Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol. Genet. Metab 104, 48–60. - PubMed
    1. Mills PB et al. (2010). Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency). Brain 133, 2148–59. - PMC - PubMed
    1. Mills PB et al. (2006). Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat. Med 12, 307–9. - PubMed
    1. Mozzarelli A and Bettati S (2006). Exploring the pyridoxal 5’-phosphate-dependent enzymes. Chem Rec 6, 275–87. - PubMed

Publication types